CONTACTStaffCAREER OPPORTUNITIESADVERTISE WITH USPRIVACY POLICYPRIVACY PREFERENCESTERMS OF USELEGAL NOTICE
© 2024 Pride Publishing Inc.
All Rights reserved
All Rights reserved
By continuing to use our site, you agree to our Private Policy and Terms of Use.
Scientists have discovered the first drug that promises to prevent prostate cancer, but deciding who should use it won't be easy because it may actually trigger aggressive tumor growth in some men who do develop the disease. The drug is already sold as a treatment for enlarged prostates under the brand name Proscar and, in a much lower dose, as Propecia for baldness. Men who took Proscar daily for seven years cut their chances of getting prostate cancer by nearly 25% compared with men given a dummy pill, researchers reported Tuesday in the New England Journal of Medicine. The results were strong enough that the study of 18,000 men age 55 and older, originally scheduled to run for another year, was stopped this month. "This trial proves prostate cancer, at least in part, is preventable," said Peter Greenwald, cancer prevention chief at the National Cancer Institute, who participated in the study himself and so far is cancer-free. "It's a huge step forward." Proscar works by preventing testosterone from changing into another hormone that fuels prostate enlargement and cancer growth. In the study, it worked equally well for men at low risk of cancer, and those at high risk--African-American men and those whose fathers and brothers had the disease. But some troubling findings have critics questioning just how often Proscar should be used. Men who developed prostate cancer while taking Proscar were more likely to have high-grade, aggressive tumors--6.4% of Proscar users were diagnosed with aggressive tumors, compared with 5.1% of men given a placebo. Impotence and loss of libido are also common side effects of the medication, particularly among older men. Nearly 220,900 U.S. men each year are diagnosed with prostate cancer. It is the second most common cancer among men after skin malignancies. An estimated 28,900 American men will die from prostate cancer in 2003.
Want more breaking equality news & trending entertainment stories?
Check out our NEW 24/7 streaming service: the Advocate Channel!
Download the Advocate Channel App for your mobile phone and your favorite streaming device!
From our Sponsors
Most Popular
Here Are Our 2024 Election Predictions. Will They Come True?
November 07 2023 1:46 PM
17 Celebs Who Are Out & Proud of Their Trans & Nonbinary Kids
November 30 2023 10:41 AM
Here Are the 15 Most LGBTQ-Friendly Cities in the U.S.
November 01 2023 5:09 PM
Which State Is the Queerest? These Are the States With the Most LGBTQ+ People
December 11 2023 10:00 AM
These 27 Senate Hearing Room Gay Sex Jokes Are Truly Exquisite
December 17 2023 3:33 PM
30 Steamy Photos of Folsom Street Fair 2023 Debauchery
October 15 2023 11:06 PM
10 Cheeky and Homoerotic Photos From Bob Mizer's Nude Films
November 18 2023 10:05 PM
42 Flaming Hot Photos From 2024's Australian Firefighters Calendar
November 10 2023 6:08 PM
These Are the 5 States With the Smallest Percentage of LGBTQ+ People
December 13 2023 9:15 AM
Here are the 15 gayest travel destinations in the world: report
March 26 2024 9:23 AM
Watch Now: Advocate Channel
Trending Stories & News
For more news and videos on advocatechannel.com, click here.
Trending Stories & News
For more news and videos on advocatechannel.com, click here.
Latest Stories
The North Face faces conservative boycott for sponsoring a queer summer camp (exclusive)
April 10 2024 8:26 AM
John Cena opens up about defending his gay brother when they were kids
April 09 2024 10:21 PM
Trans Latina Meraxes Medina killed in Los Angeles
April 09 2024 10:11 PM
Morgxn is proudly queering Southern music - here's how
April 09 2024 7:03 PM
Elon Musk uses burner accounts on X, doesn’t fact-check: report
April 09 2024 5:44 PM
Pride
Yahoo FeedDiscover endless fun at The Pride Store: Games & electronics for all ages
April 09 2024 4:25 PM
Mean Girls' Daniel Franzese on playing an HIV+ character
April 09 2024 4:19 PM